Back
ESC Professional Premium Access

Risk and benefit trade-off of thromboprophylaxis in patients with Fontan circulation: insights from the National Database of Health Insurance Claims of Japan

Session: Markers of severity and tools to handle the Fontan circulation
Topic: Pharmacotherapy
Speaker: Mr M. Hosoi (Tokyo, JP)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Mr Masayoshi Hosoi

Showa University, Tokyo (Japan)
0 follower

7 more presentations in this session

Changes in birth prevalence of hypoplastic left heart syndrome over the past half-century in Sweden

Speaker: Mr K. Giang (Gothenburg, SE)

Access
Abstract
Slides
Like
Thumbnail

The outcomes of Fontan operation in patients with hypoplastic left heart syndrome (HLHS) versus other forms of univentricular heart

Speaker: Professor A. Bielecka-Dabrowa (Lodz, PL)

Access
Abstract
Slides
Like
Thumbnail

Cardiopulmonary exercise testing in Fontan patients: unmasking the secret of Super-Fontans

Speaker: Miss M. Paiva (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Strategies for thromboprophylaxis in Fontan circulation: A network meta-analysis

Speaker: Doctor T. Alsaied (Pittsburgh, US)

Access
Abstract
Slides
Like
Thumbnail

Lymphopenia and immunoglobulin deficiency in adult patients with a Fontan circulation

Speaker: Doctor M. Possner (Bern, CH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Markers of severity and tools to handle the Fontan circulation

Speakers: Mr M. Hosoi, Mr K. Giang, Professor A. Bielecka-Dabrowa, Miss M. Paiva, Doctor T. Alsaied...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources